Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

olmesartan MeSH Supplementary Concept Data 2026


MeSH Supplementary
olmesartan
Unique ID
C437965
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C437965
Entry Term(s)
4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
CS-088
RNH 6270
omesartan
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
8W1IQP3U10
Heading Mapped to
*Imidazoles
*Tetrazoles
Frequency
808
Note
an active metabolite of CS 866
Source
J Clin Pharmacol 2001 May;41(5):515-27
Date Introduced
2001/10/26
Last Updated
2020/11/25
olmesartan Preferred
CS-088 Narrower
RNH 6270 Narrower
page delivered in 0.008s